Time distortion
Time distortion is defined as an effect that makes the passage of time feel difficult to keep track of and wildly distorted.[1] It is usually felt in two different forms, time dilation and time compression.[2] These two forms are described and documented below:
Time dilation
Time dilation is defined as the feeling that time has slowed down.[3] This commonly occurs during intense hallucinogenic experiences and seems to stem from the fact that during an intense trip, abnormally large amounts of experience are felt in very short periods of time.[4][5] This can create the illusion that more time has passed than actually has. For example, at the end of certain experiences, one may feel that they have subjectively undergone days, weeks, months, years, or even infinite periods of time.
Time dilation is often accompanied by other coinciding effects such as spirituality intensification,[6] thought loops, novelty enhancement, and internal hallucinations in a manner which may lead one into perceiving a disproportionately large number of events considering the amount of time that has actually passed in the real world. It is most commonly induced under the influence of heavy dosages of hallucinogenic compounds, such as psychedelics,[7][8] dissociatives, entactogens,[9][10] and cannabinoids.
Time compression
Time compression is defined as the experience of time speeding up and passing much quicker than it usually would while sober. For example, during this state a person may realize that an entire evening has passed them by in what feels like only a couple of hours.
This commonly occurs under the influence of certain stimulating compounds and seems to at least partially stem from the fact that during intense levels of stimulation, people typically become hyper-focused on activities and tasks in a manner which can allow time to pass them by without realizing it. However, the same experience can also occur on depressant compounds which induce amnesia. This occurs due to the way in which a person can literally forget everything that has happened while still experiencing the effects of the substance, thus giving the impression that they have suddenly jumped forward in time.
Time compression is often accompanied by other coinciding effects such as memory suppression, focus intensification, stimulation, and amnesia in a manner which may lead one into perceiving a disproportionately small number of events considering the amount of time that has actually passed in the real world. It is most commonly induced under the influence of heavy dosages of stimulating and/or amnesic compounds,[11] such as dissociatives,[12] entactogens, amphetamines, and benzodiazepines.
Time reversal
Time reversal is defined as the perception that the events, hallucinations, and experiences that occurred around one's self within the previous several minutes to several hours are spontaneously playing backwards in a manner which is somewhat similar to that of a rewinding VHS tape. During this reversal, the person's cognition and train of thought will typically continue to play forward in a coherent and linear manner while they watch the external environment around them and their body's physical actions play in reverse order. This can either occur in real time, with 5 minutes of time reversal taking approximately 5 minutes to fully rewind, or it can occur in a manner which is sped up, with 5 minutes of time reversal only taking less than a minute. It can reasonably be speculated that the experience of time reversal may potentially occur through a combination of internal hallucinations and errors in memory encoding.
Time reversal is often accompanied by other coinciding effects such as internal hallucinations, thought loops, and deja vu. It is most commonly induced under the influence of extremely heavy dosages of hallucinogenic compounds, such as psychedelics, dissociatives, and deliriants.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1B-LSD
- 1P-ETH-LAD
- 1P-LSD
- 1V-LSD
- 1cP-AL-LAD
- 1cP-LSD
- 1cP-MiPLA
- 2-FA
- 2-FEA
- 2-FMA
- 2-Fluorodeschloroketamine
- 25B-NBOH
- 25B-NBOMe
- 25C-NBOH
- 25C-NBOMe
- 25D-NBOMe
- 25E-NBOH
- 25I-NBOH
- 25I-NBOMe
- 25N-NBOMe
- 2C-B
- 2C-B-FLY
- 2C-C
- 2C-D
- 2C-E
- 2C-EF
- 2C-I
- 2C-P
- 2C-T
- 2C-T-2
- 2C-T-21
- 2C-T-7
- 3,4-CTMP
- 3-Cl-PCP
- 3-FA
- 3-FEA
- 3-FMA
- 3-FPM
- 3-HO-PCE
- 3-HO-PCP
- 3-MMC
- 3-MeO-PCE
- 3-MeO-PCMo
- 3-MeO-PCP
- 3C-E
- 3C-P
- 4-AcO-DET
- 4-AcO-DMT
- 4-AcO-DiPT
- 4-AcO-MET
Experience reports
Anecdotal reports which describe this effect within our experience index include:
- Experience: 1 tab 1P-LSD (oral) - Finding myself within the forest
- Experience: 1.5g Psilocybe Cubensis - Analysis of body and mind
- Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
- Experience: 25mg 2C-E (oral) - A mindblowing experience
- Experience: 300mg DXM (Oral) - Brink of the third
- Experience: 32mg 2C-B - Bromo Mescaline
- Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
- Experience: 40mg 5-MeO-DMT (oral) + 40mg MXE (oral) - Untitled
- Experience: 6mg:DOC - Carpet shop hell
- Experience: 80mg EPT - Bummer
- Experience: 80mg EPT - Slight improvement
- Experience:1 hit LSD (unknown dosage) - Choose Asia
- Experience:1000 Morning Glory seeds - Rediscovering the Self
- Experience:1050 µg 1cP-LSD - The matrix
- Experience:10mg & 20mg Intravenous DPT HCl - Familiar Shapes, Experiencing Death, Immersed in The Light
- Experience:110mg Diphenidine (vaporized) + 354mg DXM - instant ego death
- Experience:120mg - Garden of The Gods
- Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
- Experience:150μg tab 1P-LSD (oral) - Amazing and very long trip (20+ hours)
- Experience:2.5g Peganum Harmala + 250µg LSD - Ecstasy of Love and Misanthropy
- Experience:200 mg of MXP + N2O:20 chargers
- Experience:20mg (insufflated) - permanent all-encompassing states of unity and interconnectedness
- Experience:20mg - I looked up and saw an angry god-like figure made of clouds glaring down at me
- Experience:22mg N-Ethylhexedrone (Hexen) - A (Somewhat) Functional Stimulant at Low Doses
- Experience:25mg (insufflated) - Simultaneously amazing and horrible
- Experience:25mg - A labyrinth of organs and a storybook walk
- Experience:260 mg Ketamine (insufflated) - Lost in Paisley
- Experience:26mg - I begged the shroom aliens to kill me
- Experience:26mg - Stage 3 Trip
- Experience:2g Syrian rue + 1g Mimosa Hostilis - These voices are the building blocks of consciousness
- Experience:2mg 25C-NBOMe - Experimental trip to test personal limits of NBOMes
- Experience:2mg Etizolam & N2O - "Hippy Crack" Indeed
- Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
- Experience:3-MEO-PCMo (420mg) - Trip Report
- Experience:3.5g Syrian rue + 10g Mimosa Hostilis
- Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
- Experience:300ug LSD - Profound religious experience
- Experience:300µg AL-LAD - Don't worry, because you're everyone!
- Experience:300µg ETH-LAD - Turned Inside Out
- Experience:300µg LSD - Togetherness and the Silent Dusk
- Experience:30mg (smoked) DMT - The Monolith
- Experience:30mg Isopropylphenidate - IPPH As A Study Aid
- Experience:337mg DMT fumarate - A Day With DMT
- Experience:37mg Isopropylphenidate - Getting Shit Done With Isopropylphenidate
- Experience:3g mimosa / 3g syrian rue - Connecting with my body
- Experience:400mg DXM + 300mg DPH – Bacterial friends
- Experience:40mg DMT - Second breakthrough
- Experience:4F-EPH (15mg) - Untitled
- Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
- Experience:5g Mushrooms - Failed attempt at a Terence Mckenna style trip.
See also
External links
References
- ↑ N. Stanciu, C., M. Penders, T. (1 June 2016). "Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case". Current Psychiatry Reviews. 12 (2): 221–223.
- ↑ Nichols, D. E. (2016). "Psychedelics". Pharmacological Reviews. 68 (2): 264–355. doi:10.1124/pr.115.011478. ISSN 1521-0081.
- ↑ Pink-Hashkes, S., Rooij, I. J. E. I. van, Kwisthout, J. H. P. (2017). "Perception is in the details: A predictive coding account of the psychedelic phenomenon". London, UK : Cognitive Science Society.
- ↑ Hill, R. M.; Fischer, R.; Warshay, Diana (1969). "Effects of excitatory and tranquilizing drugs on visual perception. spatial distortion thresholds". Experientia. 25 (2): 171–172. doi:10.1007/BF01899105. ISSN 0014-4754.
- ↑ Fischer, R. (1971). "A Cartography of the Ecstatic and Meditative States". Science. 174 (4012): 897–904. doi:10.1126/science.174.4012.897. ISSN 0036-8075.
- ↑ Buckley, P. (1981). "Mystical Experience and Schizophrenia". Schizophrenia Bulletin. 7 (3): 516–521. doi:10.1093/schbul/7.3.516. ISSN 0586-7614.
- ↑ Schroll, M. A. (2013). "From ecopsychology to transpersonal ecosophy: Shamanism, psychedelics and transpersonal psychology" (PDF). European Journal of Ecopsychology. 4: 116–144.
- ↑ Riley, Sarah C.E.; Blackman, Graham (2009). "Between Prohibitions: Patterns and Meanings of Magic Mushroom Use in the UK". Substance Use & Misuse. 43 (1): 55–71. doi:10.1080/10826080701772363. ISSN 1082-6084.
- ↑ Nikolova, I.; Danchev, N. (2014). "Piperazine Based Substances of Abuse: A new Party Pills on Bulgarian Drug Market". Biotechnology & Biotechnological Equipment. 22 (2): 652–655. doi:10.1080/13102818.2008.10817529. ISSN 1310-2818.
- ↑ Yeap, C. W., Bian, C. K., Abdullah, A. F. L. (2010). "A Review on Benzylpiperazine and Trifluoromethylphenypiperazine: Origins, Effects, Prevalence and Legal Status". Health and the Environment Journal. 1 (2): 38–50.
- ↑ Griffith, John D.; Nutt, John G.; Jasinski, Donald R. (1975). "A comparison of fenfluramine and amphetamine in man". Clinical Pharmacology & Therapeutics. 18 (5part1): 563–570. doi:10.1002/cpt1975185part1563. ISSN 0009-9236.
- ↑ Corazza, Ornella; Assi, Sulaf; Schifano, Fabrizio (2013). "From "Special K" to "Special M": The Evolution of the Recreational Use of Ketamine and Methoxetamine". CNS Neuroscience & Therapeutics. 19 (6): 454–460. doi:10.1111/cns.12063. ISSN 1755-5930.